Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily

Background: In Italy, the administration of the COVID-19 vaccine booster dose started on 27 September 2021, supported by clinical trials corroborating its efficacy. Given the paucity of real-world effectiveness data, this study aims to estimate the vaccine effectiveness of the booster dose against S...

Descripción completa

Detalles Bibliográficos
Autores principales: Vella, Giuseppe, Genovese, Dario, Belluzzo, Miriam, Mazzeo, Luca, Pisciotta, Vincenzo, Amodio, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914041/
https://www.ncbi.nlm.nih.gov/pubmed/36766880
http://dx.doi.org/10.3390/healthcare11030305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914041/
https://www.ncbi.nlm.nih.gov/pubmed/36766880
http://dx.doi.org/10.3390/healthcare11030305

Ejemplares similares